Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bryant R England

Showing results (11-20 of 178) with videos related to

Pageof 18
Sort By:
Annals of the Rheumatic Diseases|February 23, 2021
Response to: 'Correspondence on 'Disease activity, cytokines, chemokines and the risk of incident diabetes in rheumatoid arthritis'' by Ruscitti <i>et al</i>Joshua F Baker, Bryant R England, Ted R Mikuls
Arthritis & Rheumatology (Hoboken, N.J.)|November 7, 2017
ReplyBryant R England, Ted R Mikuls, Jeffrey R Curtis
Biomarkers in Medicine|July 7, 2026
Peripheral biomarkers in rheumatoid arthritis-associated interstitial lung disease: a review of roles and candidatesBrent A Luedders, Scott M Matson, Bryant R England
Current Opinion in Rheumatology|October 21, 2016
Anticitrullinated protein antibodies: origin and role in the pathogenesis of rheumatoid arthritisBryant R England, Geoffrey M Thiele, Ted R Mikuls
Current Opinion in Rheumatology|January 29, 2026
Epidemiology and outcomes of rheumatoid arthritisLauren E Klingemann, Ted R Mikuls, Bryant R England
Arthritis & Rheumatology (Hoboken, N.J.)|October 28, 2024
ReplyBryant R England, Rebecca T Brooks, Ted R Mikuls
Arthritis Care & Research|November 14, 2025
Validation of a Genetic Risk Score Combined with Clinical Variables for Predicting Pulmonary Fibrosis in early Rheumatoid ArthritisMikael Brink, Austin Wheeler, Bryant R England, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|January 8, 2025
Medication adherence in rheumatoid arthritis: implications for cardiovascular disease risk and strategies to address in U.S. veteransIsaac D Smith, Bryant R England, Neha J Pagidipati, et al.
Nature Reviews. Rheumatology|May 29, 2026
The evolving comorbidity landscape of rheumatoid arthritisRebecca T Brooks, Bryant R England, Vanessa L Kronzer, et al.
BMJ (Clinical Research Ed.)|April 25, 2018
Increased cardiovascular risk in rheumatoid arthritis: mechanisms and implicationsBryant R England, Geoffrey M Thiele, Daniel R Anderson, et al.
Pageof 18

Showing results (11-20 of 178) with videos related to

Sort By:
Pageof 18
Annals of the Rheumatic Diseases|February 23, 2021
Response to: 'Correspondence on 'Disease activity, cytokines, chemokines and the risk of incident diabetes in rheumatoid arthritis'' by Ruscitti <i>et al</i>Joshua F Baker, Bryant R England, Ted R Mikuls
Arthritis & Rheumatology (Hoboken, N.J.)|November 7, 2017
ReplyBryant R England, Ted R Mikuls, Jeffrey R Curtis
Biomarkers in Medicine|July 7, 2026
Peripheral biomarkers in rheumatoid arthritis-associated interstitial lung disease: a review of roles and candidatesBrent A Luedders, Scott M Matson, Bryant R England
Current Opinion in Rheumatology|October 21, 2016
Anticitrullinated protein antibodies: origin and role in the pathogenesis of rheumatoid arthritisBryant R England, Geoffrey M Thiele, Ted R Mikuls
Current Opinion in Rheumatology|January 29, 2026
Epidemiology and outcomes of rheumatoid arthritisLauren E Klingemann, Ted R Mikuls, Bryant R England
Arthritis & Rheumatology (Hoboken, N.J.)|October 28, 2024
ReplyBryant R England, Rebecca T Brooks, Ted R Mikuls
Arthritis Care & Research|November 14, 2025
Validation of a Genetic Risk Score Combined with Clinical Variables for Predicting Pulmonary Fibrosis in early Rheumatoid ArthritisMikael Brink, Austin Wheeler, Bryant R England, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|January 8, 2025
Medication adherence in rheumatoid arthritis: implications for cardiovascular disease risk and strategies to address in U.S. veteransIsaac D Smith, Bryant R England, Neha J Pagidipati, et al.
Nature Reviews. Rheumatology|May 29, 2026
The evolving comorbidity landscape of rheumatoid arthritisRebecca T Brooks, Bryant R England, Vanessa L Kronzer, et al.
BMJ (Clinical Research Ed.)|April 25, 2018
Increased cardiovascular risk in rheumatoid arthritis: mechanisms and implicationsBryant R England, Geoffrey M Thiele, Daniel R Anderson, et al.
Pageof 18